Why a Hearing Aid Cost More Than a Laptop for Decades
A device with a few dollars of electronics routinely sold for thousands, bundled invisibly with professional services and guarded by prescription rules. Then regulators created an over the counter category and the bundle cracked open.
A Price That Did Not Match the Parts
For decades an American with hearing loss faced a startling quote: several thousand dollars, commonly four to five thousand for a pair, for devices whose components, microphone, chip, speaker, battery, cost tens of dollars. Medicare did not cover them, most insurance did not either, and an estimated majority of adults who would benefit simply went without. The gap between build cost and price was not mostly greed at the factory; it was the structure of the channel the device had to pass through.
The Bundle and the Gatekeeper
Hearing aids were regulated as prescription medical devices, purchasable only through licensed audiologists and dispensers. The professional layer is genuinely valuable, hearing loss varies enormously and fitting matters, but the pricing concealed it: the quoted price bundled the device with testing, fitting, and years of adjustments, invisibly, so the consumer could not see what either part cost or shop them separately. Behind the channel sat a manufacturing oligopoly, five or six firms supplying most of the world's devices, several of which also owned retail chains, integrating the gatekeeper. Every layer was rational; the stack of layers produced laptop prices for hearing.
| Layer | Contribution to the old price |
|---|---|
| Device manufacturing | A small fraction |
| Professional services, bundled | Large and invisible |
| Prescription only channel | No price competition from outside |
The Regulatory Experiment
In October 2022 the FDA created an over the counter category for adults with mild to moderate hearing loss, ending the prescription requirement for that population. Consumer electronics brands entered within weeks at prices from a few hundred to around a thousand dollars, sold on shelves and online. The early results have been instructive rather than explosive: uptake started slower than optimists hoped, because the barrier was never only price, stigma, denial, and the genuine usefulness of professional fitting all remain, and many buyers still conclude the audiologist adds value worth paying for. But the bundle is now visibly unbundled, professionals increasingly quote services separately, and the price umbrella over the prescription channel has a permanent hole in it.
The over the counter rule did not mainly change the device. It made the price legible, splitting a single mysterious number into a gadget anyone can compare and a service the professional now has to justify on its own.
Why This Case Generalizes
Hearing aids are the cleanest recent example of channel structure, not production cost, setting a consumer price. The same anatomy, a gatekeeper, a bundled quote, an oligopoly upstream, and insurance absent, appears across healthcare adjacent products, and the episode shows both halves of the deregulation story: prices fall and access widens at the commodity end, while the professional layer, forced to price itself explicitly, concentrates on the complex cases where it is genuinely irreplaceable. Technology keeps pressing from the consumer side, as mainstream earbuds add amplification features and blur the category boundary further.
The Bottom Line
A hearing aid cost more than a laptop because it was sold like surgery instead of like electronics: through a mandated gatekeeper, at a price that hid the split between device and service, under an oligopoly with no outside competition. One rule change unbundled it, and the market is now running the experiment in public, cheap devices for simple cases, visible service pricing for hard ones. When a price seems inexplicable, look at the channel before the product.